The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prior authorization: Patient involvement and time burden in cancer treatment.
 
Alexandra Zaleta
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
 
Julie Olson
No Relationships to Disclose
 
Fumiko Chino
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Institute for Value Based Medicine
Research Funding - Merck
 
Kim Czubaruk
Consulting or Advisory Role - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Pfizer (Inst)
 
Jalpa Doshi
Consulting or Advisory Role - Abbvie; Acadia Healthcare; Janssen; Merck; Otsuka; Takeda
Research Funding - Janssen (Inst); Merck (Inst); Spark Therapeutics (Inst)
 
Nicolas Ferreyros
No Relationships to Disclose
 
Lauren Ghazal
No Relationships to Disclose
 
Michele McCourt
No Relationships to Disclose
 
Robert Popovian
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Pfizer
Research Funding - Pfizer/GSK (Inst)
Travel, Accommodations, Expenses - Pfizer/BMS
(OPTIONAL) Uncompensated Relationships - USC School of Pharmacy
 
Christine Verini
No Relationships to Disclose